DKSH and Pfizer Partner to Help Thai Cancer Patients

DKSH and Pfizer have entered into an agreement to bring oncology and critical care medicines to improve the lives of Thai patients.

Media release

Bangkok, Thailand, August 26, 2021 – DKSH Business Unit Healthcare, Asia's leading partner for healthcare companies seeking to grow their business in Asia and beyond, has partnered with Pfizer Thailand, one of the country's leading pharmaceutical companies. The partnership aims to make oncology and critical care medicines more accessible to cancer patients in Thailand.

DKSH Thailand has been working with Pfizer Thailand since 2016 for commercial solutions of Pfizer's anti-infectives. Under this extended partnership, DKSH will now also drive growth for Pfizer's chemotherapy and critical care medicines through various commercial solutions and sales and marketing activities in hospitals across Thailand. Thanks to DKSH's large sales force and unrivaled network of hospitals and clinics in the country, cancer patients will have more access to quality pharmaceutical and medical products. This approach is in line with both DKSH's as well as Pfizer's mission to provide better healthcare to the people of Thailand.

John Clare, Vice President Healthcare, Thailand, Myanmar, Cambodia and Laos, said: “We are very proud to be working with Pfizer. This extended partnership proves that DKSH can build on good experience and trust with our existing clients to expand in other areas of their portfolio. Our partnership with Pfizer demonstrates our commitment to improving patients' health and quality of life, in line with DKSH's purpose to enrich people's lives, by providing access to healthcare, goods, services, and insights.”

For further information, please contact:

DKSH Business Unit Healthcare

Sheena Flannery

Director, Group Communications

Phone +66 2 220 9739

Sheena.flannery@dksh.com